Evidence for a Low-Threshold Approach
The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) is a multi-institutional Center of Excellence, funded by the National Institute on Drug Abuse. CHERISH is a collaborative effort among Penn LDI/University of Pennsylvania, Weill Cornell Medicine, Boston Medical Center, Boston University School of Public Health, and University of Miami Miller School of Medicine.
The mission of CHERISH is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and HIV care of people who use substances. To increase the impact of this research, CHERISH supports research conducted at the individual, system, and community levels.
The dissemination and policy core of CHERISH is led by Perelman School of Medicine faculty members and Penn LDI Fellows Zachary Meisel, Associate Professor of Emergency Medicine and Director of the Center for Emergency Care Policy Research and Margaret Lowenstein, Assistant Professor of Medicine.
CHERISH Dissemination and Policy Core
Director, Center for Emergency Care Policy Research; Associate Professor, Emergency Medicine, Perelman School of Medicine
An LDI/CHERISH Issue Brief
The Case for Universal, One-Time Screening
National Variation in Opioid Prescribing and Risk of Prolonged Use for Opioid-Naive Patients Treated in the Emergency Department for Ankle Sprains
One in Four Patients Prescribed Opioids for Ankle Sprain Between 2011-2015
Featured Blog Posts
Many State Medicaid Programs Still Require Prior Authorization for Buprenorphine Treatment for Opioid Use Disorder
Removing Barriers Could Improve Patient Outcomes
Some Doubt That It Goes Far Enough
More Needs to Be Done to Stem the Opioid Epidemic, Say LDI Experts
Q&A with Margaret (Maggie) Lowenstein
Research Supports Expanding the Practice Beyond Substance Use Disorder Treatment
Pharmacy Barriers to Buprenorphine in the United States
At-Risk Patients who Received Education Plus Naloxone in the Emergency Department Reported Increased Likelihood of Carrying it
Research Shows That Emergency Departments Can Be a Gateway to MOUDs
Potential Unintended Consequences for Patients with Sickle Cell Disease and Boney Cancer Pain
Reducing Harm, Saving Lives
Real-world effectiveness shown
CHERISH investigators model out-of-pocket price and demand